Print ISSN:-2394-2789

Online ISSN:-2394-2797

CODEN : IJPCN9

Article History

Received : 28-01-2022

Accepted : 09-02-2022



Article Metrics




Downlaod Files

   


Article Access statistics

Viewed: 548

PDF Downloaded: 546


Medicinal mushroom: What should we know?


Full Text PDF Share on Facebook Share on Twitter


Review Article

Author Details : Waill Ahmed Elkhateeb*, Ghoson Mosbah Daba

Volume : 9, Issue : 1, Year : 2022

Article Page : 1-9

https://doi.org/10.18231/j.ijpca.2022.001



Suggest article by email

Get Permission

Abstract

Mushrooms are the epigeous fruiting bodies of terrestrial fungi and as they lack cellulose and chlorophyll, they have a different lifestyle to other nonmotile life, such as plants. Mushrooms have been documented for centuries as use as food and medicine as they are generous sources of nutrients and biologically active compounds that have various applications in agriculture, food, pharmaceuticals, cosmetics, food related industries, and others. Research on various metabolic activities of medicinal mushrooms have been performed both in vitro and in vivo studies. Over the past two decades, medicinal mushrooms industry have developed greatly and today offers thousands of products to the markets. This paper describes the current status of some important world medicinal mushrooms, products, and provides suggestions for further research.


Keywords: Medicinal mushrooms, Agaricus bisporus, Agaricus blazei, Pleurotus ostreatus, Coprinus comatus, Cantharellus cibarius, Tremella fuciformis, Flammulina velutipes, Grifola frondosa, Lentinula edodes, biological activities, Traditional medicine,



How to cite : Elkhateeb W A, Daba G M, Medicinal mushroom: What should we know?. Int J Pharm Chem Anal 2022;9(1):1-9


This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.